PathoGenetix
ClosedWoburn, United States · $7.5M raised
- Headquarters
- Woburn
- Employees
- 1–10
- Business Model
- B2B
- Website
- pathogenetix.com
- Total Funding
- $7.5M
- Last Round
- $7.5M Series BNov 2011
- Rounds
- 1
About
PathoGenetix was a commercial-stage developer of an automated system for rapid bacterial identification using Genome Sequence Scanning (GSS) technology. The system could simultaneously identify thousands of bacterial strains in a single test within three hours, targeting clinical diagnostics and food safety markets. The company was based in Woburn, MA and raised multiple rounds including a $10M Series C in 2013. The company appears to have ceased active operations.
Summary
PathoGenetix is a Biotech company based in Woburn, United States. It has raised $7.5M in total across 1 round, most recently a $7.5M Series B round in Nov 2011. Investors include Ascension Health.
Funding History
Nov 2011
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/pathogenetix"><img src="https://indexed.vc/api/badge/company/pathogenetix" alt="PathoGenetix on Indexed.vc" width="260" height="76" /></a>